Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Aytu Biopharma Inc
(NQ:
AYTU
)
2.670
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,026
Open
2.670
Bid (Size)
2.710 (1)
Ask (Size)
2.740 (3)
Prev. Close
2.670
Today's Range
2.670 - 2.670
52wk Range
1.380 - 4.880
Shares Outstanding
3,780,179
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Thursday's Intraday Session
September 28, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Performance
YTD
-32.34%
-32.34%
1 Month
+58.93%
+58.93%
3 Month
+79.19%
+79.19%
6 Month
+21.36%
+21.36%
1 Year
-30.14%
-30.14%
More News
Read More
Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28
September 28, 2023
Via
Investor Brand Network
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
September 26, 2023
Via
ACCESSWIRE
Earnings Outlook For Aytu BioPharma
September 26, 2023
Via
Benzinga
Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market
June 13, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 27, 2023
Via
Benzinga
Earnings Scheduled For September 27, 2023
September 27, 2023
Via
Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
September 13, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via
Benzinga
Aytu BioPharma: Q3 Earnings Insights
May 11, 2023
Via
Benzinga
A Preview Of Aytu BioPharma's Earnings
May 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
August 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Via
Newsfile
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 31, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
July 10, 2023
Via
ACCESSWIRE
Star Equity Holdings And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
June 16, 2023
Via
Benzinga
Aytu to Participate in the Maxim Group Virtual Healthcare Conference
June 14, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director
June 09, 2023
Via
ACCESSWIRE
AYTU Stock Earnings: Aytu Misses EPS, Revenue Estimates
May 11, 2023
Via
InvestorPlace
Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results
May 11, 2023
Via
ACCESSWIRE
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
May 04, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.